|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2016. CA Cancer J Clin. 66:7–30. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ligat L, Saint-Laurent N, El-Mrani A,
Gigoux V, Al Saati T, Tomasini R, Nigri J, Dejean S, Pont F, Baer
R, et al: Pancreatic preneoplastic lesions plasma signatures and
biomarkers based on proteome profiling of mouse models. Br J
Cancer. 113:1590–1598. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Heestand GM, Murphy JD and Lowy AM:
Approach to patients with pancreatic cancer without detectable
metastases. J Clin Oncol. 33:1770–1778. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Shen R, Wang Q, Cheng S, Liu T, Jiang H,
Zhu J, Wu Y and Wang L: The biological features of PanIN initiated
from oncogenic Kras mutation in genetically engineered mouse
models. Cancer Lett. 339:135–143. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hruban RH, Adsay NV, Albores-Saavedra J,
Anver MR, Biankin AV, Boivin GP, Furth EE, Furukawa T, Klein A,
Klimstra DS, et al: Pathology of genetically engineered mouse
models of pancreatic exocrine cancer: Consensus report and
recommendations. Cancer Res. 66:95–106. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
di Magliano MP and Logsdon CD: Roles for
KRAS in pancreatic tumor development and progression.
Gastroenterology. 144:1220–1229. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hingorani SR, Petricoin EF III, Maitra A,
Rajapakse V, King C, Jacobetz MA, Ross S, Conrads TP, Veenstra TD,
Hitt BA, et al: Preinvasive and invasive ductal pancreatic cancer
and its early detection in the mouse. Cancer Cell. 4:437–450. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wagner EF: Bone development and
inflammatory disease is regulated by AP-1 (Fos/Jun). Ann Rheum Dis.
69:(Suppl 1). i86–i88. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ren X, Song W, Liu W, Guan X, Miao F, Miao
S and Wang L: Rhomboid domain containing 1 inhibits cell apoptosis
by upregulating AP-1 activity and its downstream target Bcl-3. FEBS
Lett. 587:1793–1798. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Shi R, Peng H, Yuan X, Zhang X, Zhang Y,
Fan D, Liu X and Xiong D: Down-regulation of c-fos by shRNA
sensitizes adriamycin-resistant MCF-7/ADR cells to chemotherapeutic
agents via P-glycoprotein inhibition and apoptosis augmentation. J
Cell Biochem. 114:1890–1900. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Jia ZC, Wan YL, Tang JQ, Dai Y, Liu YC,
Wang X and Zhu J: Tissue factor/activated factor VIIa induces
matrix metalloproteinase-7 expression through activation of c-Fos
via ERK1/2 and p38 MAPK signaling pathways in human colon cancer
cell. Int J Colorectal Dis. 27:437–445. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Meng Q and Xia Y: c-Jun, at the crossroad
of the signaling network. Protein Cell. 2:889–898. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lappas M, Riley C, Lim R, Barker G, Rice
GE, Menon R and Permezel M: MAPK and AP-1 proteins are increased in
term pre-labour fetal membranes overlying the cervix: Regulation of
enzymes involved in the degradation of fetal membranes. Placenta.
32:1016–1025. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Liu X, Li Q, Dowdell K, Fischer ER and
Cohen JI: Varicella-Zoster virus ORF12 protein triggers
phosphorylation of ERK1/2 and inhibits apoptosis. J Virol.
86:3143–3151. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Eferl R and Wagner EF: AP-1: A
double-edged sword in tumorigenesis. Nat Rev Cancer. 3:859–868.
2003. View
Article : Google Scholar : PubMed/NCBI
|
|
16
|
Bailey JM, Hendley AM, Lafaro KJ, Pruski
MA, Jones NC, Alsina J, Younes M, Maitra A, McAllister F,
Iacobuzio-Donahue CA, et al: P53 mutations cooperate with oncogenic
Kras to promote adenocarcinoma from pancreatic ductal cells.
Oncogene. 441:1–7. 2015.
|
|
17
|
Han H and Von Hoff DD: SnapShot:
Pancreatic cancer. Cancer Cell. 23:424–424.e1. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Stylianopoulos T, Martin JD, Chauhan VP,
Jain SR, Diop-Frimpong B, Bardeesy N, Smith BL, Ferrone CR,
Hornicek FJ, Boucher Y, et al: Causes, consequences, and remedies
for growth-induced solid stress in murine and human tumors. Proc
Natl Acad Sci USA. 109:15101–15108. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Tabernero J, Chiorean EG, Infante JR,
Hingorani SR, Ganju V, Weekes C, Scheithauer W, Ramanathan RK,
Goldstein D, Penenberg DN, et al: Prognostic factors of survival in
a randomized phase III trial (MPACT) of weekly nab-paclitaxel plus
gemcitabine versus gemcitabine alone in patients with metastatic
pancreatic cancer. Oncologist. 20:143–150. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Sherman MH, Yu RT, Engle DD, Ding N,
Atkins AR, Tiriac H, Collisson EA, Connor F, Van Dyke T, Kozlov S,
et al: Vitamin D receptor-mediated stromal reprogramming suppresses
pancreatitis and enhances pancreatic cancer therapy. Cell.
159:80–93. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Guerra C, Schuhmacher AJ, Cañamero M,
Grippo PJ, Verdaguer L, Pérez-Gallego L, Dubus P, Sandgren EP and
Barbacid M: Chronic pancreatitis is essential for induction of
pancreatic ductal adenocarcinoma by K-Ras oncogenes in adult mice.
Cancer Cell. 11:291–302. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Fukuda A, Wang SC, Morris JP IV, Folias
AE, Liou A, Kim GE, Akira S, Boucher KM, Firpo MA, Mulvihill SJ, et
al: Stat3 and MMP7 contribute to pancreatic ductal adenocarcinoma
initiation and progression. Cancer Cell. 19:441–455. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Sankaran SJ, Xiao AY, Wu LM, Windsor JA,
Forsmark CE and Petrov MS: Frequency of progression from acute to
chronic pancreatitis and risk factors: A meta-analysis.
Gastroenterology. 149:1490–1500.e1. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Carrière C, Young AL, Gunn JR, Longnecker
DS and Korc M: Acute pancreatitis accelerates initiation and
progression to pancreatic cancer in mice expressing oncogenic Kras
in the nestin cell lineage. PLoS One. 6:e277252011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Morris JP IV, Cano DA, Sekine S, Wang SC
and Hebrok M: Beta-catenin blocks Kras-dependent reprogramming of
acini into pancreatic cancer precursor lesions in mice. J Clin
Invest. 120:508–520. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
26
|
Guerra C and Barbacid M: Genetically
engineered mouse models of pancreatic adenocarcinoma. Mol Oncol.
7:232–247. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Jafri M, Donnelly B, McNeal M, Ward R and
Tiao G: MAPK signaling contributes to rotaviral-induced
cholangiocyte injury and viral replication. Surgery. 142:192–201.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Johnson GL and Lapadat R:
Mitogen-activated protein kinase pathways mediated by ERK, JNK, and
p38 protein kinases. Science. 298:1911–1912. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Garcia MN, Grasso D, Lopez-Millan MB,
Hamidi T, Loncle C, Tomasini R, Lomberk G, Porteu F, Urrutia R and
Iovanna JL: IER3 supports KRASG12D-dependent pancreatic cancer
development by sustaining ERK1/2 phosphorylation. J Clin Invest.
124:4709–4722. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
30
|
Thompson KN, Whipple RA, Yoon JR, Lipsky
M, Charpentier MS, Boggs AE, Chakrabarti KR, Bhandary L, Hessler
LK, Martin SS, et al: The combinatorial activation of the PI3K and
Ras/MAPK pathways is sufficient for aggressive tumor formation,
while individual pathway activation supports cell persistence.
Oncotarget. 6:35231–35246. 2015.PubMed/NCBI
|
|
31
|
Mace TA, Shakya R, Elnaggar O, Wilson K,
Komar HM, Yang J, Pitarresi JR, Young GS, Ostrowski MC, Ludwig T,
et al: Single agent BMS-911543 Jak2 inhibitor has distinct
inhibitory effects on STAT5 signaling in genetically engineered
mice with pancreatic cancer. Oncotarget. 6:44509–44522.
2015.PubMed/NCBI
|
|
32
|
Reichert M and Rustgi AK: Pancreatic
ductal cells in development, regeneration, and neoplasia. J Clin
Invest. 121:4572–4578. 2011. View
Article : Google Scholar : PubMed/NCBI
|
